$5.23
-0.0034-0.07%
Last update: Nov 6, 9:27 AM
Cormedix Inc
CRMDNASDAQ
Cormedix (CRMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cormedix (CRMD) last issued guidance on November 2, 2026 for fiscal year 2026. The company guided revenue in the range of $325M - $345M for the period.
Compared to prior guidance, Cormedix maintained its revenue forecast from a prior range of $325M - $345M.
Cormedix has issued 13 guidance updates between January 7, 2025 and November 2, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.24 | $0.33 | $0.83 | $0.57 |
| Actual | $0.29 | $0.43 | $0.61 | $0.57 |
| Surprise | +20.8% | +30.3% | -26.5% | 0.00% |
| Revenue | ||||
| Estimate | $95.8M | $105.9M | $127.1M | $86.0M |
| Actual | $101.9M | $127.4M | $128.6M | $104.3M |
| Surprise | +6.42% | +20.3% | +1.15% | +21.2% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.12 | $-0.01 | $-0.01 |
| Revenue | ||||
| Consensus | $52.7M | $54.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $0.29 | $0.24 | 20.8 % |
| Q1 | May 14, 2026 | $0.43 | $0.33 | 30.3 % |
| Q4 | Mar 5, 2026 | $0.61 | $0.83 | -26.5 % |
| Q3 | Nov 12, 2025 | $0.57 | $0.57 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $101.93M | $95.78M | 6.42 % |
| Q1 | May 14, 2026 | $127.43M | $105.94M | 20.3 % |
| Q4 | Mar 5, 2026 | $128.60M | $127.13M | 1.15 % |
| Q3 | Nov 12, 2025 | $104.27M | $86.02M | 21.2 % |
